Fundraising Fox

Jakob Regberg

Investor

Investment Manager at Industrifonden

About

Jakob Regberg holds an MSc in Chemistry and a PhD in Neurochemistry from Stockholm University, with a research background in peptide chemistry, drug delivery, nanomedicine, and protein engineering across Stockholm University, Karolinska Institutet, and KTH Royal Institute of Technology. He spent four years in life science investing at HealthCap and previously worked in Medical Affairs at Eisai, managing the oncology product portfolio in the Nordic region. He joined Industrifonden in 2025 and focuses on life science and health-related investments.

Contact· self-published, not guessed

Invests in

BiotechDeep TechHealthtechMedical Devices

Investments

Investor

AgteriaAnaCardioBrainzellPurpose PharmaTeitur TrophicsToxotech

Per the firm's website.

Colleagues at Industrifonden

Frequently asked questions

Who is Jakob Regberg?
Jakob Regberg holds an MSc in Chemistry and a PhD in Neurochemistry from Stockholm University, with a research background in peptide chemistry, drug delivery, nanomedicine, and protein engineering across Stockholm University, Karolinska Institutet, and KTH Royal Institute of Technology. He spent four years in life science investing at HealthCap and previously worked in Medical Affairs at Eisai, managing the oncology product portfolio in the Nordic region. He joined Industrifonden in 2025 and focuses on life science and health-related investments.
Where does Jakob Regberg work?
Jakob Regberg is Investment Manager at Industrifonden.
What does Jakob Regberg invest in?
Jakob Regberg invests in Biotech, Deep Tech, Healthtech, Medical Devices.
What companies has Jakob Regberg invested in?
Investments tracked here include Agteria, AnaCardio, Brainzell, Purpose Pharma, Teitur Trophics, Toxotech.